Novavax (NVAX) FCF Margin (QoQ) (2010 - 2026)
Novavax (NVAX) FCF Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 630.00 |
| Dec 31, 2025 | -18,525.00 |
| Sep 30, 2025 | 22,759.00 |
| Jun 30, 2025 | -4,472.00 |
| Mar 31, 2025 | 16,740.00 |
| Dec 31, 2024 | -2,295.00 |
| Sep 30, 2024 | -24,830.00 |
| Jun 30, 2024 | 16,609.00 |
| Mar 31, 2024 | -4,235.00 |
| Dec 31, 2023 | -517.00 |
| Sep 30, 2023 | -210.00 |
| Jun 30, 2023 | 36,615.00 |
| Mar 31, 2023 | -39,126.00 |
| Dec 31, 2022 | -133.00 |
| Sep 30, 2022 | 6,861.00 |
| Jun 30, 2022 | -6,791.00 |
| Mar 31, 2022 | 12,197.00 |
| Dec 31, 2021 | -5,064.00 |
| Sep 30, 2021 | -12,809.00 |
| Jun 30, 2021 | -10,444.00 |